Logo
x

Search

Subscribe Now

Vertex

Vertex Receives the US FDA Approval for Journavx (Suzetrigine) to Treat Acute Pain

Vertex Receives the US FDA Approval for Journavx (Suzetrigine) to Treat Acute Pain

  • January 30, 2025
The US FDA Approves Vertex’s Alyftrek for the Treatment of Cystic Fibrosis

The US FDA Approves Vertex’s Alyftrek for the Treatment of Cystic Fibrosis

  • December 20, 2024
PharmaShots Weekly Snapshots (April 08 – April 12, 2024)

PharmaShots Weekly Snapshots (April 08 – April 12, 2024)

  • April 12, 2024
Vertex to Acquire Alpine Immune Sciences for ~$4.9B

Vertex to Acquire Alpine Immune Sciences for ~$4.9B

  • April 11, 2024
Vertex Receives CHMP’s Positive Opinion for Kalydeco as a Treatment of Cystic Fibrosis in Infants

Vertex Receives CHMP’s Positive Opinion for Kalydeco as a Treatment of Cystic Fibrosis in Infants

  • February 23, 2024
Insights+: EMA Marketing Authorization of New Drugs in November 2023

Insights+: EMA Marketing Authorization of New Drugs in November 2023

  • December 29, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.